Cargando…

Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development

Background: Targeted toxins require multiple treatments and therefore must be deimmunized. We report a method of protein deimmunization based on the point mutation of highly hydrophilic R, K, D, E, and Q amino acids on the molecular surface of truncated diphtheria-toxin (DT390). Methods: Based on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmohl, Joerg U., Todhunter, Deborah, Oh, Seung, Vallera, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626721/ https://www.ncbi.nlm.nih.gov/pubmed/26473923 http://dx.doi.org/10.3390/toxins7104067

Ejemplares similares

Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies
por: Schmohl, Joerg U., et al.
Publicado: (2018)

Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker
por: Schmohl, Joerg U., et al.
Publicado: (2016)

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
por: Oh, Felix, et al.
Publicado: (2018)

Optimization algorithms for functional deimmunization of therapeutic proteins
por: Parker, Andrew S, et al.
Publicado: (2010)

Design and Engineering of Deimmunized Vaccinia Viral Vectors
por: Song, Kevin, et al.
Publicado: (2020)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins
por: Grinberg, Yehudit, et al.
Publicado: (2017)

Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015)

Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
por: Zinsli, Léa V., et al.
Publicado: (2020)

Potency of a Human Monoclonal Antibody to Diphtheria Toxin Relative to Equine Diphtheria Anti-toxin in an Animal Model
por: Smith, Heidi, et al.
Publicado: (2015)

THE PRODUCTION OF DIPHTHERIA TOXIN
por: Park, W. H., et al.
Publicado: (1896)

ON THE NATURE OF DIPHTHERIA TOXIN
por: Dernby, Karl Gustav
Publicado: (1926)

Diphtheria and Anti-Toxine
por: Crombie, A.
Publicado: (1895)

Diphtheria Anti-Toxin
Publicado: (1898)

The Complexity of Diphtheria Toxin
Publicado: (1914)

Diphtheria and Anti-Toxin
Publicado: (1897)

Anti-Toxine for Diphtheria
Publicado: (1897)

Diphtheria and Anti-Toxin
Publicado: (1896)

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
por: Mett, Vadim, et al.
Publicado: (2021)

The Anti-Toxin Treatment of Diphtheria
Publicado: (1894)

Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model
por: Smith, Heidi L., et al.
Publicado: (2016)

Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing
por: Zhao, Hongliang, et al.
Publicado: (2020)

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach
por: Winterling, Karina, et al.
Publicado: (2021)

Identification of diphtheria toxin receptor and a nonproteinous diphtheria toxin-binding molecule in Vero cell membrane
Publicado: (1988)

Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria
por: Smith, Heidi L., et al.
Publicado: (2017)

Topography of Diphtheria Toxin's T Domain in the Open Channel State
por: Senzel, Lisa, et al.
Publicado: (2000)

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
por: Khlusevich, Yana, et al.
Publicado: (2022)

THE EFFECTS OF DIPHTHERIA TOXIN ON THE CECROPIA SILKWORM
por: Pappenheimer, A. M., et al.
Publicado: (1952)

THE NEUTRALIZATION OR DESTRUCTION OF DIPHTHERIA TOXIN BY TISSUE
por: Wadsworth, Augustus, et al.
Publicado: (1931)

ACTION OF DIPHTHERIA TOXIN IN THE GUINEA PIG
por: Baseman, Joel B., et al.
Publicado: (1970)

Diphtheria Anti-Toxin in Epidemic Measles
Publicado: (1898)

Antitoxin. I. The Production of Diphtheria Toxin
por: Park, William Hallock
Publicado: (1895)

Diphtheria Anti-Toxin Specific for Influenza
Publicado: (1918)

Diphtheria and the So-called Anti-toxine
por: Mathew, Jos. Fitz
Publicado: (1896)

Diphtheria and the So-called Anti-Toxine
por: Mathew, Joseph Fitz
Publicado: (1896)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
por: Oh, Felix, et al.
Publicado: (2020)

Entry of diphtheria toxin into cells: possible existence of cellular factor(s) for entry of diphtheria toxin into cells was studied in somatic cell hybrids and hybrid toxins
Publicado: (1984)

Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
por: Schmohl, Jörg U., et al.
Publicado: (2017)

Epitope Mapping of the Diphtheria Toxin and Development of an ELISA-Specific Diagnostic Assay
por: De-Simone, Salvatore Giovanni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rrctuhehfh5bqeu8b5v7sl0cco